Boston, MA · Founded 2021 · Privately Held (backing)
Developer of a liquid biopsy platform designed to provide resolution into disease-defining biology from a blood test. Precede Biosciences is based in Boston, MA and was founded in 2021. Its last reported valuation was $199 million in Oct 2025. It has raised $132 million.
Last reported valuation
$198.5M
Oct 2026
Priced at
—
Total raised
$132.0M
Last round
—
Team — not yet on record
No current team members for Precede Biosciences are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Precede Biosciences with a free account
·The complete investor list: 17 names
·Watch Precede Biosciences: the Monday email on marks, rounds and moves
